Merck’s $1.3bn bet on cancer therapy: Inside the Modifi Biosciences acquisition

Merck & Co., a global leader in pharmaceuticals, has acquired Modifi Biosciences, a cutting-edge biotech startup based in New Haven, Connecticut, for up to $1.3 ... Read More